Healthcare research from Bristol Myers Squibb, page 5
A filtered view. Show the full list.
Refine
Listings
-
ArticleClinical therapeutics
Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: Analysis of Number Needed To Treat and Number Needed To Harm
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleEClinicalMedicine
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)
Prognostic value of patient-reported outcomes in advanced or metastatic melanoma patients treated with immunotherapy: Findings from the CheckMate-067 study
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Effect of light source and UVA quotient on monoclonal antibody stability during ambient light exposure studies
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
-
ArticleESMO open
Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleESMO open
Risk profiles and incidence of cardiovascular events across different cancer types
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
ArticleESMO open
Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
ArticleJACC. Advances
Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleJACC. Basic to translational science
Proteome-Wide Genetic Investigation of Large Artery Stiffness
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source
Disease researchAdded
-
Clinical trial reportJournal of the American College of Cardiology
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
Clinical trial reportJournal of the American College of Cardiology
Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Public healthAdded
-
Clinical trial reportJACC. Clinical electrophysiology
Atrial Fibrillation Burden on a 14-Day ECG Monitor: Findings From the GUARD-AF Trial Screening Arm
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Public healthAdded
-
ArticleJournal of lipid research
Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Research dataAdded
-
ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Assessing the Content Validity of Preference-Based Measures in Cancer
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
A Methodological Study to Compare Alternative Modes of Administration With Value EQ-5D Using Preference-Elicitation Techniques
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleLeukemia research
Incidence of second primary malignancies in relapsed/refractory B-cell non-Hodgkin's lymphoma patients in England
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Public healthAdded
-
Clinical trial reportLeukemia research
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
ReviewMatrix biology : journal of the International Society for Matrix Biology
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
ArticleMultiple sclerosis and related disorders
Comparative efficacy and safety of ozanimod and ponesimod for relapsing multiple sclerosis: A matching-adjusted indirect comparison
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ReviewMolecular therapy. Methods & clinical development
Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirements
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleThrombosis research
Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleThrombosis research
Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
Clinical trial reportCell reports. Medicine
Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myeloma
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded